Reproduction, Fertility and Development Reproduction, Fertility and Development Society
Vertebrate reproductive science and technology


J. H. Martins A , M. I. S. Silva B , G. A. Crepaldi C , W. O. Melo D and J. R. S. Torres-Júnior B
+ Author Affiliations
- Author Affiliations

A State University of Maranhão, São Luís, Brazil;

B Agrarian and Environmental Sciences Center, Federal University of Maranhão, CCAA/UFMA, Chapadinha, Brazil;

C Animal Reproduction Department, FMVZ/USP, São Paulo, Brazil;

D Federal Rural University of Amazon, Parauapebas, Brazil

Reproduction, Fertility and Development 22(1) 171-172
Published: 8 December 2009


The objective of this study was to evaluate the effect of reutilization of intravaginal progesterone devices on pregnancy rate of lactating and nonlactating Nelore cows submitted to fixed-time AI (FTAI). The study used 684 lactating cows (50 to 70 days postpartum) and 361 nonlactating cows (210 to 240 days postpartum). At random stages of the estrous cycle (Day 0), all animals received 2 mg of estradiol benzoate (Estrogin®, Farmavet, São Paulo, Brazil) and the animals of each category (lactating or nonlactating) were allocated in 1 of 2 treatments (new or used). Thus, the 4 groups consisted of lactating/new, lactating/used, nonlactating/new and nonlactating/used. The animals of lactating/new and nonlactating/new groups received a new intravaginal progesterone device (1 g of P4, DIB®, Intervet/Schering-Plough, São Paulo, Brazil) and the cows of lactating/used and nonlactating/used groups received a similar device that had previously been used for 8 days. At the time of P4 device removal (Day 8), the cows were treated with 150 μg of cloprostenol (Preloban®, Intervet/Schering-Plough), 1 mg of estradiol cypionate (ECP®, Pfizer, São Paulo, Brazil), and 300 IU of eCG (Folligon®, Intervet/Schering-Plough). The cows were FTAI on Day 10 (48 to 52 h after device removal). To evaluate the pregnancy rate, an ultrasonographic examination (CHISON 500VET, USP Brasil Eletromedicina, São Paulo, Brazil) was performed 30 days after the FTAI. Data were analyzed using the GENMOD procedure of SAS (SAS Institute, Cary, NC, USA).There was no interaction between treatment and BCS, AI bull, or technician. The pregnancy rates for the groups were 155/300 (51.7%a for lactating/new, 200/384 (52.1%a for lactating/used, 52/154 (33.8%b for nonlactating/new, and 96/207 (46.2%a for nonlactating/used (P = 0.0007). A reduction in pregnancy rate for nonlactating cows occurred when the intravaginal progesterone device was new. Although serum progesterone was not measured in the current trial, it is very likely that this finding might be explained by the high cyclicity rates in beef cows after weaning (210 days postpartum) and by the presence of CL producing additional support of progesterone besides the high P4 from the new device (Baruselli et al. 2004 Anim. Reprod. Sci. 82, 479-486). Many researchers found that greater circulating progesterone concentrations during progesterone implant treatment reduced LH pulsatility, LH follicular receptors, and follicular growth (Ireland and Roche, 1982 J. Reprod. Fertil. 64, 295-302). Furthermore, it seems likely that the presence of smaller-sized ovulatory follicles might contribute to ovulation failures, delayed ovulation, smaller CL area, and decrease in the pregnancy rate (Carvalho et al. 2008 Theriogenology 69, 167-175). In conclusion, lactating cows can be fixed-time inseminated using a new or a previously used DIB® as progesterone source. However, for nonlactating cows, a previously used device may increase pregnancy rates.

USP Brasil Eletromedicina, ABS Pecplan and Fazendas Reunidas Rio Bravo.

Export Citation Cited By (1)